An Open-label, Randomized, Three-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Conventional Pump Therapy in Regulating Glucose Levels During 24 Hours in Adults and Adolescents With Type 1 Diabetes
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Glucagon; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 04 Jul 2014 Biomarkers information updated
- 21 Jan 2013 New trial record